Copyright
©The Author(s) 2022.
World J Clin Cases. Aug 6, 2022; 10(22): 7708-7719
Published online Aug 6, 2022. doi: 10.12998/wjcc.v10.i22.7708
Published online Aug 6, 2022. doi: 10.12998/wjcc.v10.i22.7708
Variables | Median (range) / n (%) |
Clavien-Dindo stage | |
None | 109 (35.5%) |
I | 27 (8.8%) |
II | 121 (39.4%) |
IIIa | 28 (9.1%) |
IIIb | 4 (1.3%) |
IV | 4 (1.3%) |
IVa | 8 (2.6%) |
IVb | 6 (2.0%) |
CCI, median (range) | 20.9 (0, 96.6) |
Anastomotic leakage | 75 (24.4%) |
Secondary operation | 7 (2.3%) |
Hypoalbuminemia | 88 (28.7%) |
Pulmonary infection | 68 (22.1%) |
Recurrence | 11 (3.6%) |
Metastasis | 21 (6.8%) |
In-hospital mortality | 52 (16.9%) |
30-day mortality | 61 (19.9%) |
90-day mortality | 78 (25.4%) |
- Citation: Shi MK, Mei YQ, Shi JL. Short- (30-90 days) and mid-term (1-3 years) outcomes and prognostic factors of patients with esophageal cancer undergoing surgical treatments. World J Clin Cases 2022; 10(22): 7708-7719
- URL: https://www.wjgnet.com/2307-8960/full/v10/i22/7708.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i22.7708